RPHM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 17.90%

Insider Buying (Last 12 Months): $993,097.95

Insider Selling (Last 12 Months): $0.00

Reneo Pharmaceuticals Insider Trading History Chart

Reneo Pharmaceuticals Share Price & Price History

^$1.82

▲ +0.09 (5.20%)

As of 10/4/2024 05:00 PM ET

Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong

From Brownstone Research | Ad

Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.

Click here to watch this demo and decide for yourself.

Reneo Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/24/2024	Braden Michael Leonard	Major Shareholder	Buy	29,600	$1.41	$41,736.00	3,388,649
9/17/2024	Braden Michael Leonard	Major Shareholder	Buy	55,300	$1.36	$75,208.00	3,358,243
8/13/2024	Braden Michael Leonard	Major Shareholder	Buy	171,339	$1.39	$238,161.21	2,843,533
5/14/2024	Braden Michael Leonard	Major Shareholder	Buy	414,281	$1.54	$637,992.74	2,672,194
8/28/2023	Ashley Hall	Insider	Sell	15,625	$6.28	$98,125.00	39,600
6/23/2023	Holdings A/S Novo	Major Shareholder	Sell	100,000	$7.10	$710,000.00	3,330,337
5/8/2023	Niall O'donnell	Director	Buy	125,000	$8.00	$1,000,000.00	2,188,713
8/31/2022	Michael Cruse	COO	Buy	3,212	$3.21	$10,310.52	6,197
8/29/2022	Michael Cruse	COO	Buy	83	$3.24	$268.92	30,783

Rare "crisis signal" triggers for third time in U.S. market

From Stansberry Research | Ad

A rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the market crashed 78% (the dot-com bust) and 89% (the Great Depression). Today, according to one of America's leading experts (who has predicted nearly every financial crisis of the last 25 years), what's coming next could soon crash the market by 50% or more, and keep it down for 10, 20, or even 30 years.

Click here for all the details.

SEC Filings (Institutional Ownership Changes) for Reneo Pharmaceuticals (NASDAQ:RPHM)

90.98% of Reneo Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Reneo Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	214,499	$0.37M	0.0%	+6.7%	0.642%
11/15/2024	Ikarian Capital LLC	1,025,668	$1.74M	0.2%	N/A	3.068%
11/14/2024	Vestal Point Capital LP	799,400	$1.36M	0.1%	+46.7%	2.391%
11/5/2024	BML Capital Management LLC	3,457,395	$5.88M	3.5%	+29.4%	10.342%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	18,027	$27K	0.0%	N/A	0.054%
8/20/2024	Nantahala Capital Management LLC	547,804	$0.85M	0.0%	N/A	1.639%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	18,027	$27K	0.0%	N/A	0.054%
8/12/2024	Highbridge Capital Management LLC	2,915,376	$4.40M	0.1%	+6.5%	8.723%
8/9/2024	Renaissance Technologies LLC	442,200	$0.67M	0.0%	-25.5%	1.323%
5/7/2024	Marquette Asset Management LLC	73,770	$0.12M	0.0%	N/A	0.221%
5/2/2024	Fifth Lane Capital LP	32,635	$54K	0.0%	-18.4%	0.098%
4/23/2024	BML Capital Management LLC	2,177,913	$3.62M	2.4%	+65.7%	6.517%
2/15/2024	Octagon Capital Advisors LP	2,250,000	$3.60M	0.6%	-1.3%	6.754%
2/14/2024	Pale Fire Capital SE	30,100	$48K	0.0%	+102.7%	0.090%
2/14/2024	Vestal Point Capital LP	400,000	$0.64M	0.1%	N/A	1.201%
2/12/2024	Highbridge Capital Management LLC	1,121,704	$1.80M	0.1%	N/A	3.367%
2/7/2024	Jump Financial LLC	25,315	$41K	0.0%	N/A	0.076%
1/30/2024	BML Capital Management LLC	1,314,229	$2.10M	1.6%	N/A	3.945%
1/12/2024	SG Americas Securities LLC	22,097	$35K	0.0%	N/A	0.066%
11/15/2023	Adage Capital Partners GP L.L.C.	65,000	$0.50M	0.0%	N/A	0.192%
11/14/2023	Eventide Asset Management LLC	2,078,142	$15.83M	0.3%	+18.8%	6.148%
11/14/2023	Pale Fire Capital SE	14,851	$0.11M	0.0%	N/A	0.044%
11/7/2023	Dorsey Wright & Associates	3,673	$28K	0.0%	N/A	0.011%
11/7/2023	Barclays PLC	78,118	$0.60M	0.0%	+5.7%	0.231%
10/24/2023	Bank of New York Mellon Corp	35,963	$0.27M	0.0%	+13.1%	0.106%
9/8/2023	Tucker Asset Management LLC	36,753	$0.24M	0.1%	N/A	0.109%
8/14/2023	Great Point Partners LLC	1,083,317	$7.11M	1.4%	+796.3%	3.218%
8/11/2023	Franklin Resources Inc.	1,345,145	$8.82M	0.0%	+230.0%	3.996%
8/11/2023	ExodusPoint Capital Management LP	555,316	$3.64M	0.0%	+125.9%	1.650%
8/4/2023	American International Group Inc.	4,659	$31K	0.0%	N/A	0.014%
8/4/2023	Carlyle Group Inc.	2,698,957	$17.68M	0.6%	+30.1%	8.019%
8/2/2023	MAI Capital Management	66,487	$0.44M	0.0%	+24.4%	0.198%
6/1/2023	Prelude Capital Management LLC	14,800	$89K	0.0%	N/A	0.044%
5/16/2023	Great Point Partners LLC	120,864	$0.72M	0.1%	N/A	0.481%
5/11/2023	ExodusPoint Capital Management LP	245,787	$1.47M	0.0%	+77.3%	0.979%
5/10/2023	MAI Capital Management	53,428	$0.32M	0.0%	+96.2%	0.213%
5/8/2023	Federated Hermes Inc.	78,390	$0.47M	0.0%	-2.0%	0.312%
5/5/2023	Carlyle Group Inc.	2,073,957	$12.24M	0.4%	N/A	8.259%
2/15/2023	Tang Capital Management LLC	30,587	$71K	0.0%	N/A	0.125%
2/9/2023	MAI Capital Management	27,232	$63K	0.0%	-56.9%	0.111%
2/1/2023	Bank of Montreal Can	33,500	$80K	0.0%	N/A	0.137%
11/14/2022	Ergoteles LLC	37,640	$0.13M	0.0%	-11.2%	0.153%
11/3/2022	Barclays PLC	71,930	$0.24M	0.0%	+33.3%	0.294%
9/16/2022	Federated Hermes Inc.	30,000	$80K	0.0%	+76.5%	0.123%
5/4/2022	Commonwealth Equity Services LLC	22,347	$65K	0.0%	N/A	0.091%
5/4/2022	Tybourne Capital Management HK Ltd.	700,000	$2.06M	0.1%	-6.7%	2.862%
2/10/2022	Qube Research & Technologies Ltd	13,482	$0.12M	0.0%	N/A	0.055%
2/8/2022	Northern Trust Corp	63,547	$0.54M	0.0%	+7.7%	0.260%
2/1/2022	Qube Research & Technologies Ltd	13,482	$0.12M	0.0%	N/A	0.055%
11/15/2021	Rock Springs Capital Management LP	1,143,185	$8.52M	0.2%	+1.3%	4.684%
11/15/2021	Franklin Resources Inc.	450,000	$3.35M	0.0%	-10.0%	1.844%
11/9/2021	BlackRock Inc.	294,281	$2.19M	0.0%	+1.5%	1.206%
11/2/2021	New York State Common Retirement Fund	4,210	$31K	0.0%	-67.6%	0.017%
8/17/2021	Caas Capital Management LP	20,000	$0.19M	0.0%	N/A	0.082%
8/16/2021	California State Teachers Retirement System	8,726	$81K	0.0%	N/A	0.036%
8/16/2021	RA Capital Management L.P.	62,217	$0.58M	0.0%	N/A	0.255%
8/16/2021	Tudor Investment Corp Et Al	13,406	$0.13M	0.0%	N/A	0.055%
8/16/2021	Pinz Capital Management LP	56,823	$0.53M	0.2%	N/A	0.233%
8/16/2021	Charles Schwab Investment Management Inc.	13,371	$0.13M	0.0%	N/A	0.055%
8/16/2021	State Street Corp	60,915	$0.57M	0.0%	N/A	0.250%
8/16/2021	Federated Hermes Inc.	17,000	$0.16M	0.0%	N/A	0.070%
8/13/2021	Northern Trust Corp	68,447	$0.64M	0.0%	N/A	0.282%
8/13/2021	Franklin Resources Inc.	500,000	$4.67M	0.0%	N/A	2.059%
8/13/2021	Geode Capital Management LLC	72,069	$0.67M	0.0%	N/A	0.297%
8/13/2021	Vanguard Group Inc.	366,210	$3.42M	0.0%	N/A	1.508%
8/13/2021	FMR LLC	187,500	$1.75M	0.0%	N/A	0.772%
8/12/2021	JPMorgan Chase & Co.	7,794	$73K	0.0%	N/A	0.032%
8/11/2021	RiverVest Venture Management LLC	2,409,220	$22.48M	4.4%	N/A	9.920%
8/11/2021	Bank of New York Mellon Corp	14,837	$0.14M	0.0%	N/A	0.061%
8/11/2021	BlackRock Inc.	289,824	$2.70M	0.0%	N/A	1.193%
8/11/2021	Deutsche Bank AG	3,745	$35K	0.0%	N/A	0.015%
8/10/2021	Nicholas Investment Partners LP	226,189	$2.11M	0.1%	N/A	0.931%
8/6/2021	Aisling Capital Management LP	886,075	$8.27M	1.3%	N/A	3.649%
8/2/2021	New York State Common Retirement Fund	12,980	$0.12M	0.0%	N/A	0.053%
8/2/2021	NEA Management Company LLC	4,786,921	$44.66M	0.6%	N/A	19.711%

Data available starting January 2016

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. The company's lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.

Today's Range

Now: $1.82

$1.68

$1.90

50 Day Range

MA: $1.64

$1.31

$1.82

52 Week Range

Now: $1.82

$0.98

$9.21

Volume

437,500 shs

Average Volume

250,384 shs

Market Capitalization

$60.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.21

Who are the company insiders with the largest holdings of Reneo Pharmaceuticals?: Reneo Pharmaceuticals' top insider shareholders include:
Braden Michael Leonard (Major Shareholder)
Holdings A/S Novo (Major Shareholder)
Niall O'donnell (Director)
Ashley Hall (Insider)
Learn More about top insider investors at Reneo Pharmaceuticals.
Who are the major institutional investors of Reneo Pharmaceuticals?: Reneo Pharmaceuticals' top institutional investors include:
BML Capital Management LLC — 10.34%
Ikarian Capital LLC — 3.07%
Vestal Point Capital LP — 2.39%
Geode Capital Management LLC — 0.64%
Learn More about top institutional investors of Reneo Pharmaceuticals stock.
Which major investors are buying Reneo Pharmaceuticals stock?: In the previous quarter, RPHM stock was acquired by institutional investors including:
Ikarian Capital LLC
BML Capital Management LLC
Vestal Point Capital LP
Geode Capital Management LLC
During the last year, these company insiders have bought Reneo Pharmaceuticals stock:
Braden Michael Leonard (Major Shareholder)
Holdings A/S Novo (Major Shareholder)
Learn More investors buying Reneo Pharmaceuticals stock.